Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer. Tong X, Patel AS, Kim E, Li H, et al. Cancer Cell 2024 Feb 20:S1535-6108(24)00036-9. doi: 10.1016/j.ccell.2024.

Read + Share

Amedeo Smart

Independent Medical Education

Tong X, Patel AS, Kim E, Li H, et al. Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer. Cancer Cell 2024 Feb 20:S1535-6108(24)00036-9. doi: 10.1016/j.ccell.2024.
PMID: 38402609